Oxurion NV (OXUR.BR)

EUR 0.27

(0.0%)

Total Assets Summary of Oxurion NV

  • Oxurion NV's latest annual total assets in 2023 was 6.55 Million EUR , down -45.38% from previous year.
  • Oxurion NV's latest quarterly total assets in 2024 Q2 was 4.55 Million EUR , down 0.0% from previous quarter.
  • Oxurion NV reported annual total assets of 11.99 Million EUR in 2022, down -36.46% from previous year.
  • Oxurion NV reported annual total assets of 18.87 Million EUR in 2021, down -44.94% from previous year.
  • Oxurion NV reported quarterly total assets of 6.55 Million EUR for 2023 FY, down -45.38% from previous quarter.
  • Oxurion NV reported quarterly total assets of 6.55 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Oxurion NV (2023 - 2006)

Historical Annual Total Assets of Oxurion NV (2023 - 2006)

Year Total Assets Total Assets Growth
2023 6.55 Million EUR -45.38%
2022 11.99 Million EUR -36.46%
2021 18.87 Million EUR -44.94%
2020 34.28 Million EUR -47.28%
2019 65.03 Million EUR -43.39%
2018 114.86 Million EUR -23.65%
2017 150.43 Million EUR 23.68%
2016 121.63 Million EUR -32.03%
2015 178.94 Million EUR -18.92%
2014 220.71 Million EUR -18.6%
2013 271.15 Million EUR 13.37%
2012 239.17 Million EUR 85.28%
2011 129.08 Million EUR -9.69%
2010 142.93 Million EUR 41.22%
2009 101.21 Million EUR 50.62%
2008 67.2 Million EUR 29.24%
2007 51.99 Million EUR 39.28%
2006 37.33 Million EUR 0.0%

Peer Total Assets Comparison of Oxurion NV

Name Total Assets Total Assets Difference
ABIONYX Pharma SA 14.71 Million EUR 55.472%
ABIVAX Société Anonyme 327.06 Million EUR 97.997%
Adocia SA 24.95 Million EUR 73.754%
Aelis Farma SA 26.28 Million EUR 75.077%
Biophytis S.A. 11.93 Million EUR 45.124%
Advicenne S.A. 12.4 Million EUR 47.207%
genOway Société anonyme 31.84 Million EUR 79.43%
IntegraGen SA 8 Million EUR 18.129%
Medesis Pharma S.A. 1.92 Million EUR -240.024%
Neovacs S.A. 47.53 Million EUR 86.22%
NFL Biosciences SA 3.97 Million EUR -64.961%
Plant Advanced Technologies SA 14.91 Million EUR 56.078%
Quantum Genomics Société Anonyme 3.74 Million EUR -74.817%
Sensorion SA 46.49 Million EUR 85.912%
Theranexus Société Anonyme 7.23 Million EUR 9.502%
TME Pharma N.V. 2.49 Million EUR -162.947%
Valbiotis SA 33.24 Million EUR 80.3%
TheraVet SA 7.53 Million EUR 13.063%
Valerio Therapeutics Société anonyme 35.27 Million EUR 81.431%
argenx SE 4.11 Billion EUR 99.841%
BioSenic S.A. 9.55 Million EUR 31.478%
Celyad Oncology SA 16.28 Million EUR 59.772%
DBV Technologies S.A. 165.65 Million USD 96.046%
Galapagos NV 4.35 Billion EUR 99.85%
Genfit S.A. 173.87 Million EUR 96.233%
GeNeuro SA 6.31 Million EUR -3.756%
Hyloris Pharmaceuticals SA 47.68 Million EUR 86.263%
Innate Pharma S.A. 184.19 Million EUR 96.444%
Inventiva S.A. 69.13 Million EUR 90.526%
MaaT Pharma SA 42.93 Million EUR 84.743%
MedinCell S.A. 36.94 Million EUR 82.272%
Nanobiotix S.A. 93.89 Million EUR 93.024%
Onward Medical N.V. 43.62 Million EUR 84.987%
Oryzon Genomics S.A. 106.9 Million EUR 93.873%
OSE Immunotherapeutics SA 81.9 Million EUR 92.002%
Pharming Group N.V. 426.33 Million EUR 98.464%
Poxel S.A. 4.82 Million EUR -35.808%
GenSight Biologics S.A. 9.08 Million EUR 27.919%
Transgene SA 45.21 Million EUR 85.514%
Financière de Tubize SA 1.92 Billion EUR 99.659%
UCB SA 15.53 Billion EUR 99.958%
Valneva SE 469.39 Million EUR 98.605%
Vivoryon Therapeutics N.V. 30.82 Million EUR 78.754%